Apogee Therapeutics
PublicApogee Therapeutics is now publicly traded
The data on this page reflects Apogee Therapeutics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Jul 18, 2023
Last Round
—
—
Total Funding Raised
$345M
Company Overview
Apogee Therapeutics is a biotechnology company developing innovative biologics for the treatment of atopic dermatitis, chronic obstructive pulmonary disease, and related inflammatory and immunology conditions.
Sector
Biotech
AI Layer
Non-AI
Keywords
Apogee Therapeutics Comparables
Compare Apogee Therapeutics with similar companies based on industry and business-model similarity.
No public comparables are available for Apogee Therapeutics. Request access to learn about comparables coverage.
Request accessApogee Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Jul 18, 2023 |
Key People
Founding team and executive leadership
Apogee Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jefferies | IPO |
| Guggenheim Securities | IPO |
| Wedbush | IPO |
| TD Cowen | IPO |
| Stifel Financial Corp. | IPO |
Apogee Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access